147 related articles for article (PubMed ID: 25223486)
1. Glucocorticoid prescriptions and breast cancer recurrence: a Danish nationwide prospective cohort study.
Lietzen LW; Ahern T; Christiansen P; Jensen AB; Sørensen HT; Lash TL; Cronin-Fenton DP
Ann Oncol; 2014 Dec; 25(12):2419-2425. PubMed ID: 25223486
[TBL] [Abstract][Full Text] [Related]
2. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
Ahern TP; Pedersen L; Tarp M; Cronin-Fenton DP; Garne JP; Silliman RA; Sørensen HT; Lash TL
J Natl Cancer Inst; 2011 Oct; 103(19):1461-8. PubMed ID: 21813413
[TBL] [Abstract][Full Text] [Related]
3. Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.
Falstie-Jensen AM; Kjærsgaard A; Lorenzen EL; Jensen JD; Reinertsen KV; Dekkers OM; Ewertz M; Cronin-Fenton DP
Breast Cancer Res; 2019 Mar; 21(1):44. PubMed ID: 30902106
[TBL] [Abstract][Full Text] [Related]
4. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
[TBL] [Abstract][Full Text] [Related]
5. Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.
Cronin-Fenton DP; Heide-Jørgensen U; Ahern TP; Lash TL; Christiansen P; Ejlertsen B; Sørensen HT
Epidemiology; 2016 Jul; 27(4):586-93. PubMed ID: 27007644
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune diseases and breast cancer recurrence: a Danish nationwide cohort study.
Lietzen LW; Cronin-Fenton D; Christiansen P; Sørensen HT; Lash TL
Breast Cancer Res Treat; 2015 Jan; 149(2):497-504. PubMed ID: 25555832
[TBL] [Abstract][Full Text] [Related]
7. Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study.
Sørensen GV; Cronin-Fenton DP; Sørensen HT; Ulrichsen SP; Pedersen L; Lash TL
Breast Cancer Res; 2012 Feb; 14(1):R21. PubMed ID: 22305057
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.
Cronin-Fenton D; Kjærsgaard A; Nørgaard M; Amelio J; Liede A; Hernandez RK; Sørensen HT
Breast Cancer Res Treat; 2018 Jan; 167(2):517-528. PubMed ID: 28948396
[TBL] [Abstract][Full Text] [Related]
9. Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.
Harborg S; Heide-Jørgensen U; Ahern TP; Ewertz M; Cronin-Fenton D; Borgquist S
Breast Cancer Res Treat; 2020 Aug; 183(1):153-160. PubMed ID: 32572715
[TBL] [Abstract][Full Text] [Related]
10. Pre-admission use of glucocorticoids and 30-day mortality following colorectal cancer surgery: a population-based Danish cohort study.
Ostenfeld EB; Erichsen R; Thorlacius-Ussing O; Riis AH; Sørensen HT
Aliment Pharmacol Ther; 2014 Apr; 39(8):843-53. PubMed ID: 24611938
[TBL] [Abstract][Full Text] [Related]
11. Opioids and breast cancer recurrence: A Danish population-based cohort study.
Cronin-Fenton DP; Heide-Jørgensen U; Ahern TP; Lash TL; Christiansen PM; Ejlertsen B; Sjøgren P; Kehlet H; Sørensen HT
Cancer; 2015 Oct; 121(19):3507-14. PubMed ID: 26207518
[TBL] [Abstract][Full Text] [Related]
12. Statins and pancreatic cancer risk in patients with chronic pancreatitis: A Danish nationwide population-based cohort study.
Kirkegård J; Lund JL; Mortensen FV; Cronin-Fenton D
Int J Cancer; 2020 Feb; 146(3):610-616. PubMed ID: 30861115
[TBL] [Abstract][Full Text] [Related]
13. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
[TBL] [Abstract][Full Text] [Related]
14. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.
Bens A; Friis S; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Cronin-Fenton D; Mellemkjær L
Prev Med; 2018 Nov; 116():186-193. PubMed ID: 30261243
[TBL] [Abstract][Full Text] [Related]
15. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.
Cetin K; Christiansen CF; Sværke C; Jacobsen JB; Sørensen HT
BMJ Open; 2015 Apr; 5(4):e007702. PubMed ID: 25926150
[TBL] [Abstract][Full Text] [Related]
16. New and chronic use of hypnotics after diagnosis with early breast cancer. A retrospective cohort study.
Andersen LT; Suppli NP; Dalton SO; Kroman N; Rosenberg J; Gögenur I
Acta Oncol; 2015 May; 54(5):704-11. PubMed ID: 25752966
[TBL] [Abstract][Full Text] [Related]
17. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer recurrence after reoperation for surgical bleeding.
Pedersen RN; Bhaskaran K; Heide-Jørgensen U; Nørgaard M; Christiansen PM; Kroman N; Sørensen HT; Cronin-Fenton DP
Br J Surg; 2017 Nov; 104(12):1665-1674. PubMed ID: 28782800
[TBL] [Abstract][Full Text] [Related]
19. Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women.
Cairat M; Al Rahmoun M; Gunter MJ; Heudel PE; Severi G; Dossus L; Fournier A
BMC Med; 2021 Aug; 19(1):186. PubMed ID: 34340701
[TBL] [Abstract][Full Text] [Related]
20. Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database.
Cronin-Fenton D; Lash TL; Ahern TP; Damkier P; Christiansen P; Ejlertsen B; Sørensen HT
Acta Oncol; 2018 Jan; 57(1):120-128. PubMed ID: 29202630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
